Univax Biologics Inc Report issue

For profit Phase 1
Founded: Rockville MD United States (1988)
Status: Acquired by Nabi Biopharmaceuticals (1995) → now Vaxart (2017)

Organization Overview

First Clinical Trial
1999
NCT00002248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (1)

cryptosporidium immune whey protein concentrate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cryptosporidiosis (Phase 1)

Enteritis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1